|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1992-10-29
|
|
pubmed:abstractText |
Different approaches are being followed to enhance the immunogenicity of established and newly developed vaccines. Some of them foresee the utilization of carrier molecules recognized by the immune systems of a large proportion of the human population. Others are directed mainly towards the development of improved adjuvants and delivery systems.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0952-7915
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
454-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1388847-Adjuvants, Immunologic,
pubmed-meshheading:1388847-Animals,
pubmed-meshheading:1388847-Antibody Formation,
pubmed-meshheading:1388847-Antigen-Presenting Cells,
pubmed-meshheading:1388847-Carrier Proteins,
pubmed-meshheading:1388847-Mice,
pubmed-meshheading:1388847-Mice, Inbred BALB C,
pubmed-meshheading:1388847-T-Lymphocytes, Helper-Inducer,
pubmed-meshheading:1388847-Vaccines
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
New carriers and adjuvants in the development of vaccines.
|
|
pubmed:affiliation |
World Health Organization, University of Geneva, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|
